Your browser doesn't support javascript.
loading
Lenalidomide as an Alternative to Thalidomide for Treatment of Recurrent Erythema Multiforme.
Drahy, Faustine; Ingen-Housz-Oro, Saskia; Grootenboer-Mignot, Sabine; Wolkenstein, Pierre; Chosidow, Olivier.
Afiliação
  • Drahy F; Department of Dermatology, Assistance Publique-Hôpitaux de Paris, Henri Mondor Hospital, Créteil, France.
  • Ingen-Housz-Oro S; Department of Dermatology, Assistance Publique-Hôpitaux de Paris, Henri Mondor Hospital, Créteil, France.
  • Grootenboer-Mignot S; EA 7379 EpiDermE (Epidemiologie en Dermatologie et Evaluation des Thérapeutiques), Université Paris-Est Créteil Val de Marne, Créteil, France.
  • Wolkenstein P; Referral Center for Toxic Bullous Diseases, Créteil, France.
  • Chosidow O; Department of Immunology, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France.
JAMA Dermatol ; 154(4): 487-489, 2018 04 01.
Article em En | MEDLINE | ID: mdl-29450445

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Eritema Multiforme / Lenalidomida / Fatores Imunológicos Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Eritema Multiforme / Lenalidomida / Fatores Imunológicos Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article